Mary Mosher

Array ( [id] => 1056094 [patent_doc_number] => 06855317 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-02-15 [patent_title] => 'Immunological herpes simplex virus antigens and methods for use thereof' [patent_app_type] => utility [patent_app_number] => 10/073834 [patent_app_country] => US [patent_app_date] => 2002-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 19383 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/855/06855317.pdf [firstpage_image] =>[orig_patent_app_number] => 10073834 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1137712 [patent_doc_number] => 06780618 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-08-24 [patent_title] => 'Method for improving genetic stability of foreign insert nucleotide sequence in recombinant poliovirus' [patent_app_type] => B2 [patent_app_number] => 10/071867 [patent_app_country] => US [patent_app_date] => 2002-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 23 [patent_no_of_words] => 15287 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/780/06780618.pdf [firstpage_image] =>[orig_patent_app_number] => 10071867 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6175628 [patent_doc_number] => 20020155434 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-24 [patent_title] => 'Hepatitis B virus treatment' [patent_app_type] => new [patent_app_number] => 10/068059 [patent_app_country] => US [patent_app_date] => 2002-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 13989 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20020155434.pdf [firstpage_image] =>[orig_patent_app_number] => 10068059 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1178294 [patent_doc_number] => 06740324 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-05-25 [patent_title] => 'Methods and compositions useful for stimulating an immune response' [patent_app_type] => B2 [patent_app_number] => 10/061943 [patent_app_country] => US [patent_app_date] => 2002-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 18573 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/740/06740324.pdf [firstpage_image] =>[orig_patent_app_number] => 10061943 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7468130 [patent_doc_number] => 20040120971 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-24 [patent_title] => 'Biodegradable carrier and method for preparation thereof' [patent_app_type] => new [patent_app_number] => 10/473774 [patent_app_country] => US [patent_app_date] => 2003-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2848 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20040120971.pdf [firstpage_image] =>[orig_patent_app_number] => 10473774 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1101367 [patent_doc_number] => 06815160 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-11-09 [patent_title] => 'Hepatitis C viral antigen immunoassay detection systems' [patent_app_type] => B1 [patent_app_number] => 10/048191 [patent_app_country] => US [patent_app_date] => 2002-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 8675 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/815/06815160.pdf [firstpage_image] =>[orig_patent_app_number] => 10048191 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1167584 [patent_doc_number] => 06753137 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-06-22 [patent_title] => 'Circulating epstein-barr virus DNA in the serum of patients with gastric carcinoma' [patent_app_type] => B2 [patent_app_number] => 10/057579 [patent_app_country] => US [patent_app_date] => 2002-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6075 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/753/06753137.pdf [firstpage_image] =>[orig_patent_app_number] => 10057579 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6778525 [patent_doc_number] => 20030049606 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-13 [patent_title] => 'Novel anti-viral and anti-proliferative agents derived from STAT1 transcription factor' [patent_app_type] => new [patent_app_number] => 10/054965 [patent_app_country] => US [patent_app_date] => 2002-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7381 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20030049606.pdf [firstpage_image] =>[orig_patent_app_number] => 10054965 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7306810 [patent_doc_number] => 20040116664 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-17 [patent_title] => 'Recombinant oligomeric protein complexes with enhanced immunogenic potential' [patent_app_type] => new [patent_app_number] => 10/466655 [patent_app_country] => US [patent_app_date] => 2003-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 8584 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20040116664.pdf [firstpage_image] =>[orig_patent_app_number] => 10466655 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6468331 [patent_doc_number] => 20020151033 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-17 [patent_title] => 'Replication-competent virus expressing a detectable fusion protein' [patent_app_type] => new [patent_app_number] => 10/050673 [patent_app_country] => US [patent_app_date] => 2002-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 6165 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0151/20020151033.pdf [firstpage_image] =>[orig_patent_app_number] => 10050673 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6518757 [patent_doc_number] => 20020192185 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-19 [patent_title] => 'Recombinant protein production in bovine adenovirus expression vector system' [patent_app_type] => new [patent_app_number] => 10/046938 [patent_app_country] => US [patent_app_date] => 2002-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 51 [patent_no_of_words] => 17672 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20020192185.pdf [firstpage_image] =>[orig_patent_app_number] => 10046938 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1132570 [patent_doc_number] => 06783762 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-08-31 [patent_title] => 'Product and method for obtaining specific immunization with one or more antigens' [patent_app_type] => B1 [patent_app_number] => 09/890379 [patent_app_country] => US [patent_app_date] => 2002-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6743 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 129 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/783/06783762.pdf [firstpage_image] =>[orig_patent_app_number] => 09890379 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 322451 [patent_doc_number] => 07517683 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-14 [patent_title] => 'HIV-like particles and the use thereof' [patent_app_type] => utility [patent_app_number] => 10/466134 [patent_app_country] => US [patent_app_date] => 2002-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 12508 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/517/07517683.pdf [firstpage_image] =>[orig_patent_app_number] => 10466134 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1240773 [patent_doc_number] => 06682742 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-01-27 [patent_title] => 'Vector for integration of heterologous sequences into poxviral genomes' [patent_app_type] => B1 [patent_app_number] => 09/980029 [patent_app_country] => US [patent_app_date] => 2001-12-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4166 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/682/06682742.pdf [firstpage_image] =>[orig_patent_app_number] => 09980029 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6525634 [patent_doc_number] => 20020192640 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-19 [patent_title] => 'Purified active HCV NS2/3 protease' [patent_app_type] => new [patent_app_number] => 10/017736 [patent_app_country] => US [patent_app_date] => 2001-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 11845 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20020192640.pdf [firstpage_image] =>[orig_patent_app_number] => 10017736 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1204645 [patent_doc_number] => 06716431 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-04-06 [patent_title] => 'Differential cytotoxicity of alternative forms of rotavirus nonstructural protein 4' [patent_app_type] => B1 [patent_app_number] => 10/048540 [patent_app_country] => US [patent_app_date] => 2001-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 7788 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/716/06716431.pdf [firstpage_image] =>[orig_patent_app_number] => 10048540 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6840013 [patent_doc_number] => 20030037353 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-20 [patent_title] => 'Animal model for flaviviridae infection' [patent_app_type] => new [patent_app_number] => 10/006524 [patent_app_country] => US [patent_app_date] => 2001-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 12632 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20030037353.pdf [firstpage_image] =>[orig_patent_app_number] => 10006524 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6342038 [patent_doc_number] => 20020034735 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-21 [patent_title] => 'Efficient purification of adenovirus' [patent_app_type] => new [patent_app_number] => 09/997909 [patent_app_country] => US [patent_app_date] => 2001-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5681 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20020034735.pdf [firstpage_image] =>[orig_patent_app_number] => 09997909 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6842571 [patent_doc_number] => 20030147918 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-07 [patent_title] => 'Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use' [patent_app_type] => new [patent_app_number] => 09/995791 [patent_app_country] => US [patent_app_date] => 2001-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 66 [patent_figures_cnt] => 66 [patent_no_of_words] => 37439 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20030147918.pdf [firstpage_image] =>[orig_patent_app_number] => 09995791 [rel_patent_id] =>[rel_patent_doc_number] =>)